Safety and efficacy of succimer in toddlers with blood lead levels of 20-44 μg/dL

W. J. Rogan, R. L. Bornschein, Jr Chisolm, A. I. Damokosh, D. W. Dockery, M. E. Fay, R. L. Jones, G. G. Rhoads, N. B. Ragan, M. Salganik, D. F. Schwarz, J. H. Ware, R. P. Wedeen, J. Serwint, M. Brophy, C. T. Davoli, M. B. Denckla, M. R. Farfel, G. W. Goldstein, J. RubinO. Berger, K. N. Dietrich, C. Wesolowski, S. Wilkins, G. Maynard-Wentzel, M. E. Mortensen, S. Adubato, M. Elsafty, M. Heenehan, A. Sheffet, A. Ty, C. Campbell, F. M. Gill, J. Guinn, F. Henretig, D. Knight, J. Radcliffe, D. F. Schwarz, B. B. Bowman, E. Gunter, D. Huff, D. T. Miller, D. C. Paschal, A. J. Bernstein, T. V. Kotlov, C. R. Angle, J. Faison, S. H. Gehlbach, B. Gray-Little, S. A. James, L. A. Moye, H. L. Needleman

Research output: Contribution to journalArticle

Abstract

Although lead encephalopathy has virtually disappeared from the United States, thousands of children still have sufficient lead exposure to produce cognitive impairment. It is not known whether treating children with blood lead levels < 45 μg/dL (2.2 μM) is beneficial and can be done with acceptable safety. We conducted a 780-child, placebo-controlled, randomized trial of up to three courses of succimer in children with blood lead levels of 20-44 μg/dL (1.0-2.1 μM). Children were aged 12-33 mo, 77% were African-American, 7% were Hispanic, and they lived in deteriorating inner city housing. Placebo-treated children had a gradual decrease in blood lead level. Succimer-treated children had an abrupt drop in blood lead level, followed by rebound. The mean blood lead level of the succimer-treated children during the 6 mo after initiation of treatment was 4.5 μg/dL (95% confidence intervals, 3.7 to 5.3 μg/dL; 0.22 μM, 0.18 to 0.26 μM) lower than that of placebo-treated children. There were more scalp rashes in succimer-treated children (3.5% versus 1.3%) and an unanticipated excess of trauma. Succimer lowers blood lead level with few side effects. The unanticipated excess of trauma requires confirmation.

Original languageEnglish (US)
Pages (from-to)593-599
Number of pages7
JournalPediatric research
Volume48
Issue number5
DOIs
StatePublished - 2000
Externally publishedYes

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Fingerprint Dive into the research topics of 'Safety and efficacy of succimer in toddlers with blood lead levels of 20-44 μg/dL'. Together they form a unique fingerprint.

Cite this